Application and expression of NR4A2 gene in pituitary adenoma biomarker
A 1. NR4A2, pituitary adenoma technology, applied in the field of use of natural ribonucleotides, can solve the problems of fast growth of tumor residual tissue, poor tumor curative effect, limited radiotherapy sensitivity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0017] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention. The present invention will be further described below in conjunction with specific embodiment
[0018] 1. Experimental materials, clinical samples: tissue samples of 19 cases of pituitary adenoma (8 cases of invasive pituitary adenoma, 9 cases of non-invasive pituitary adenoma) were provided by the Second Affiliated Hospital of Dalian Medical University.
[0019] Reagents: NR4A2 screening primers were synthesized by Invitrogen; RNAiso Plus (product number 9109) ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com